BioSpace News Archive

Pharm Country

Sanofi launches “The 1 Pledge” movement to drive early screening for type 1 diabetes in the U.S.

Sanofi, a leader in diabetes care, launched “The 1 Pledge” movement, a nationwide education campaign urging families to get screened for type 1 diabetes so that those who will eventually be affected by the disease can begin to prepare as soon as possible.

November 1, 2023
·
9 min read
BioMidwest

UCB presents latest data from generalized myasthenia gravis portfolio at 2023 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session

UCB announced that it will be presenting results from across its portfolio in generalized myasthenia gravis at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting and the Myasthenia Gravis Association of America Scientific Session taking place November 1-4, 2023.

November 1, 2023
·
25 min read
South Rampart Pharma Expands Global Patent Portfolio with EU Approval for FDA Fast-Tracked SRP-001 for Pain

South Rampart Pharma, Inc. announced today the issuance of European Patent No. 3672938 by the European Patent Office (EPO) effective November 1, 2023.

November 1, 2023
·
5 min read
Business

REGENXBIO to Host Conference Call on November 8 to Discuss Third Quarter 2023 Financial Results and Recent Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, November 8, 2023, at 4:30 p.m. EST to discuss its financial results for the quarter ended September 30, 2023, and recent operational highlights.

November 1, 2023
·
1 min read
Biotech Beach

Diality to Unveil Moda-flx Hemodialysis System, Poster Data at ASN Kidney Week 2023

Diality Inc. today announced that it will introduce its Moda-flx Hemodialysis System™ at ASN Kidney Week 2023, Nov. 1-5 at the Pennsylvania Convention Center in Philadelphia.

November 1, 2023
·
1 min read
Business

Daewoong Pharmaceutical Reports Third Quarter 2023 Financial Results

Daewoong Pharmaceutical is pleased to announce its financial results for the third quarter of 2023.

November 1, 2023
·
3 min read
Pharm Country

ViroCell and Great Ormond Street Hospital Poised to Unlock Clinical Trial ‘Backlog’ Following MHRA Manufacturing Approval

ViroCell Biologics announces that the Company is now able to manufacture and globally export viral vectors from Great Ormond Street Hospital’s state-of-the-art manufacturing facility, the Zayed Centre for Research, for use in clinical trials.

November 1, 2023
·
5 min read
Business

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced the appointment of Tim Van Hauwermeiren to its board of directors.

November 1, 2023
·
4 min read
NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support

NorthX Biologics AB is excited to announce the launch of its proprietary plasmids for the efficient manufacture of AAV vectors for gene therapy.

November 1, 2023
·
2 min read
Drug Development

SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting

SpringWorks Therapeutics, Inc. announced the presentation of additional data from the Phase 3 DeFi trial at the 2023 Connective Tissue Oncology Society Annual Meeting, being held November 1-4, 2023.

November 1, 2023
·
14 min read